—

Print
Save
Email this link

Share Link

Copy this link, or click below to email it to a friend
Email this link
or copy the link directly:

https://erc.bioscientifica.com/search?access=all&page=2&pageSize=10&q=oestrogen&sort=relevance
The link was not copied. Your current browser may not support copying via this button.

Link copied successfully

Search Results

You are looking at 11 - 20 of 430 items for :

oestrogen x

Refine by access: All content x

Clear All

Expression and functional consequences of oestrogen and progesterone receptors in human insulinomas

Edward B Alabraba

Edward B Alabraba
Search for other papers by Edward B Alabraba in
Google Scholar
PubMed

Philippe Taniere

Philippe Taniere Liver Research Group, Department of Pathology,, Endocrine Research Group,, Liver Unit,, University of Birmingham, Birmingham B15 2TT, UK

Search for other papers by Philippe Taniere in
Google Scholar
PubMed

Gary M Reynolds

Gary M Reynolds
Search for other papers by Gary M Reynolds in
Google Scholar
PubMed

Paul M Stewart

Paul M Stewart Liver Research Group, Department of Pathology,, Endocrine Research Group,, Liver Unit,, University of Birmingham, Birmingham B15 2TT, UK

Search for other papers by Paul M Stewart in
Google Scholar
PubMed

Stephen J Wigmore

Stephen J Wigmore
Search for other papers by Stephen J Wigmore in
Google Scholar
PubMed

, and

Simon R Bramhall

Simon R Bramhall Liver Research Group, Department of Pathology,, Endocrine Research Group,, Liver Unit,, University of Birmingham, Birmingham B15 2TT, UK

Search for other papers by Simon R Bramhall in
Google Scholar
PubMed

confined to endocrine pancreas tissue ( Doglioni et al . 1990 , Viale et al . 1992 ). A decade ago, oestrogen receptor (ER) presence was demonstrated in pancreatic tumour tissue using radioligand binding assays and Scatchard analysis ( Greenway et al

Article Type:: Research Article

DOI:: https://doi.org/10.1677/ERC-07-0093

Volume/Issue:: Volume 14: Issue 4

Free access

Growth factor signalling and resistance to selective oestrogen receptor modulators and pure anti-oestrogens: the use of anti-growth factor therapies to treat or delay endocrine resistance in breast cancer

R I Nicholson

R I Nicholson Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff University, Cardiff, UK

Search for other papers by R I Nicholson in
Google Scholar
PubMed

I R Hutcheson

I R Hutcheson Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff University, Cardiff, UK

Search for other papers by I R Hutcheson in
Google Scholar
PubMed

S E Hiscox

S E Hiscox Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff University, Cardiff, UK

Search for other papers by S E Hiscox in
Google Scholar
PubMed

J M Knowlden

J M Knowlden Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff University, Cardiff, UK

Search for other papers by J M Knowlden in
Google Scholar
PubMed

M Giles

M Giles Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff University, Cardiff, UK

Search for other papers by M Giles in
Google Scholar
PubMed

D Barrow

D Barrow Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff University, Cardiff, UK

Search for other papers by D Barrow in
Google Scholar
PubMed

, and

J M W Gee

J M W Gee Tenovus Centre for Cancer Research, Welsh School of Pharmacy, Cardiff University, Cardiff, UK

Search for other papers by J M W Gee in
Google Scholar
PubMed

Introduction In oestrogen-sensitive breast cancer cells, it is widely believed that locally and distally produced growth factors engage intracellular signalling pathways that productively cross-talk with oestrogen receptor (ER

Article Type:: Research Article

DOI:: https://doi.org/10.1677/erc.1.00991

Volume/Issue:: Volume 12: Issue Supplement_1

Free access

Lymph/angiogenesis contributes to sex differences in lung cancer through oestrogen receptor alpha signalling

Charline Dubois

Charline Dubois Laboratory of Tumour and Development Biology, GIGA-Cancer, University of Liège, CHU-B23, Liège, Belgium

Search for other papers by Charline Dubois in
Google Scholar
PubMed

Natacha Rocks

Natacha Rocks Laboratory of Tumour and Development Biology, GIGA-Cancer, University of Liège, CHU-B23, Liège, Belgium

Search for other papers by Natacha Rocks in
Google Scholar
PubMed

Silvia Blacher

Silvia Blacher Laboratory of Tumour and Development Biology, GIGA-Cancer, University of Liège, CHU-B23, Liège, Belgium

Search for other papers by Silvia Blacher in
Google Scholar
PubMed

Irina Primac

Irina Primac Laboratory of Tumour and Development Biology, GIGA-Cancer, University of Liège, CHU-B23, Liège, Belgium

Search for other papers by Irina Primac in
Google Scholar
PubMed

Anne Gallez

Anne Gallez Laboratory of Tumour and Development Biology, GIGA-Cancer, University of Liège, CHU-B23, Liège, Belgium

Search for other papers by Anne Gallez in
Google Scholar
PubMed

Melissa García-Caballero

Melissa García-Caballero Laboratory of Tumour and Development Biology, GIGA-Cancer, University of Liège, CHU-B23, Liège, Belgium

Search for other papers by Melissa García-Caballero in
Google Scholar
PubMed

Céline Gérard

Céline Gérard Laboratory of Tumour and Development Biology, GIGA-Cancer, University of Liège, CHU-B23, Liège, Belgium

Search for other papers by Céline Gérard in
Google Scholar
PubMed

Laurent Brouchet

Laurent Brouchet Thoracic Surgery Department, University Hospital CHU Toulouse, Toulouse, France

Search for other papers by Laurent Brouchet in
Google Scholar
PubMed

Agnès Noël

Agnès Noël Laboratory of Tumour and Development Biology, GIGA-Cancer, University of Liège, CHU-B23, Liège, Belgium

Search for other papers by Agnès Noël in
Google Scholar
PubMed

Françoise Lenfant

Françoise Lenfant INSERM UMR1048, Institut des Maladies Métaboliques et Cardiovasculaires – I2MC, University of Toulouse III Paul Sabatier, UPS, Toulouse, France

Search for other papers by Françoise Lenfant in
Google Scholar
PubMed

Didier Cataldo

Didier Cataldo Laboratory of Tumour and Development Biology, GIGA-Cancer, University of Liège, CHU-B23, Liège, Belgium

Search for other papers by Didier Cataldo in
Google Scholar
PubMed

, and

Christel Pequeux

Christel Pequeux Laboratory of Tumour and Development Biology, GIGA-Cancer, University of Liège, CHU-B23, Liège, Belgium

Search for other papers by Christel Pequeux in
Google Scholar
PubMed

contribution of oestrogens to lung cancer development ( Siegfried & Stabile 2014 , Rodriguez-Lara et al . 2018 ). Indeed, elevated 17b-oestradiol (E2) levels and higher expression of aromatase predict lower overall survival in lung cancer patients ( Mah et

Article Type:: Research Article

DOI:: https://doi.org/10.1530/ERC-18-0328

Volume/Issue:: Volume 26: Issue 2

Free access

Oestrogens, Beatson and endocrine therapy

A Howell

A Howell
Search for other papers by A Howell in
Google Scholar
PubMed

R B Clarke

R B Clarke
Search for other papers by R B Clarke in
Google Scholar
PubMed

, and

E Anderson

E Anderson
Search for other papers by E Anderson in
Google Scholar
PubMed

Article Type:: Research Article

DOI:: https://doi.org/10.1677/erc.0.0403371

Volume/Issue:: Volume 4: Issue 3

Restricted access

The anti-oestrogen ICI 182,780, but not tamoxifen, inhibits the growth of MCF-7 breast cancer cells refractory to long-term oestrogen deprivation through down-regulation of oestrogen receptor and IGF signalling

L-A Martin

L-A Martin
Search for other papers by L-A Martin in
Google Scholar
PubMed

S Pancholi

S Pancholi
Search for other papers by S Pancholi in
Google Scholar
PubMed

C M W Chan

C M W Chan
Search for other papers by C M W Chan in
Google Scholar
PubMed

I Farmer

I Farmer
Search for other papers by I Farmer in
Google Scholar
PubMed

C Kimberley

C Kimberley
Search for other papers by C Kimberley in
Google Scholar
PubMed

M Dowsett

M Dowsett
Search for other papers by M Dowsett in
Google Scholar
PubMed

, and

S R D Johnston

S R D Johnston
Search for other papers by S R D Johnston in
Google Scholar
PubMed

Introduction Most patients with oestrogen receptor (ER)-positive advanced breast cancer who have relapsed on tamoxifen (TAM) are prescribed aromatase inhibitors. Unlike TAM, which competes with oestrogen for the ER, aromatase

Article Type:: Research Article

DOI:: https://doi.org/10.1677/erc.1.00905

Volume/Issue:: Volume 12: Issue 4

Free access

Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition

R Kaaks

R Kaaks
Search for other papers by R Kaaks in
Google Scholar
PubMed

S Rinaldi

S Rinaldi
Search for other papers by S Rinaldi in
Google Scholar
PubMed

T J Key

T J Key
Search for other papers by T J Key in
Google Scholar
PubMed

F Berrino

F Berrino
Search for other papers by F Berrino in
Google Scholar
PubMed

P H M Peeters

P H M Peeters
Search for other papers by P H M Peeters in
Google Scholar
PubMed

C Biessy

C Biessy
Search for other papers by C Biessy in
Google Scholar
PubMed

L Dossus

L Dossus
Search for other papers by L Dossus in
Google Scholar
PubMed

A Lukanova

A Lukanova
Search for other papers by A Lukanova in
Google Scholar
PubMed

S Bingham

S Bingham
Search for other papers by S Bingham in
Google Scholar
PubMed

K-T Khaw

K-T Khaw
Search for other papers by K-T Khaw in
Google Scholar
PubMed

N E Allen

N E Allen
Search for other papers by N E Allen in
Google Scholar
PubMed

H B Bueno-de-Mesquita

H B Bueno-de-Mesquita
Search for other papers by H B Bueno-de-Mesquita in
Google Scholar
PubMed

C H van Gils

C H van Gils
Search for other papers by C H van Gils in
Google Scholar
PubMed

D Grobbee

D Grobbee
Search for other papers by D Grobbee in
Google Scholar
PubMed

H Boeing

H Boeing
Search for other papers by H Boeing in
Google Scholar
PubMed

P H Lahmann

P H Lahmann
Search for other papers by P H Lahmann in
Google Scholar
PubMed

G Nagel

G Nagel
Search for other papers by G Nagel in
Google Scholar
PubMed

J Chang-Claude

J Chang-Claude
Search for other papers by J Chang-Claude in
Google Scholar
PubMed

F Clavel-Chapelon

F Clavel-Chapelon
Search for other papers by F Clavel-Chapelon in
Google Scholar
PubMed

A Fournier

A Fournier
Search for other papers by A Fournier in
Google Scholar
PubMed

A Thiébaut

A Thiébaut
Search for other papers by A Thiébaut in
Google Scholar
PubMed

C A González

C A González
Search for other papers by C A González in
Google Scholar
PubMed

J R Quirós

J R Quirós
Search for other papers by J R Quirós in
Google Scholar
PubMed

M-J Tormo

M-J Tormo
Search for other papers by M-J Tormo in
Google Scholar
PubMed

E Ardanaz

E Ardanaz
Search for other papers by E Ardanaz in
Google Scholar
PubMed

P Amiano

P Amiano
Search for other papers by P Amiano in
Google Scholar
PubMed

V Krogh

V Krogh
Search for other papers by V Krogh in
Google Scholar
PubMed

D Palli

D Palli
Search for other papers by D Palli in
Google Scholar
PubMed

S Panico

S Panico
Search for other papers by S Panico in
Google Scholar
PubMed

R Tumino

R Tumino
Search for other papers by R Tumino in
Google Scholar
PubMed

P Vineis

P Vineis
Search for other papers by P Vineis in
Google Scholar
PubMed

A Trichopoulou

A Trichopoulou
Search for other papers by A Trichopoulou in
Google Scholar
PubMed

V Kalapothaki

V Kalapothaki
Search for other papers by V Kalapothaki in
Google Scholar
PubMed

D Trichopoulos

D Trichopoulos
Search for other papers by D Trichopoulos in
Google Scholar
PubMed

P Ferrari

P Ferrari
Search for other papers by P Ferrari in
Google Scholar
PubMed

T Norat

T Norat
Search for other papers by T Norat in
Google Scholar
PubMed

R Saracci

R Saracci
Search for other papers by R Saracci in
Google Scholar
PubMed

, and

E Riboli

E Riboli
Search for other papers by E Riboli in
Google Scholar
PubMed

interpreted as being the result of a longer lifetime exposure to elevated sex steroids, particularly oestrogens, which may inhibit apoptosis and stimulate proliferation of the mammary duct epithelium ( Pike et al . 1993 , Key et al . 2001 ). Finally, among

Article Type:: Research Article

DOI:: https://doi.org/10.1677/erc.1.01038

Volume/Issue:: Volume 12: Issue 4

Free access

Downstream targets of growth factor and oestrogen signalling and endocrine resistance: the potential roles of c-Myc, cyclin D1 and cyclin E

Alison J Butt

Alison J Butt
Search for other papers by Alison J Butt in
Google Scholar
PubMed

Catriona M McNeil

Catriona M McNeil
Search for other papers by Catriona M McNeil in
Google Scholar
PubMed

Elizabeth A Musgrove

Elizabeth A Musgrove
Search for other papers by Elizabeth A Musgrove in
Google Scholar
PubMed

, and

Robert L Sutherland

Robert L Sutherland
Search for other papers by Robert L Sutherland in
Google Scholar
PubMed

disease. A major issue for the development of novel endocrine therapies is that, although oestrogen has been implicated as a major etiological factor in the tumorigenic process in the breast, the downstream effects of its actions remain to be fully

Article Type:: Research Article

DOI:: https://doi.org/10.1677/erc.1.00993

Volume/Issue:: Volume 12: Issue Supplement_1

Free access

The ERβ5 splice variant increases oestrogen responsiveness of ERα^pos Ishikawa cells

Frances Collins

Frances Collins The University of Edinburgh Centre for Inflammation Research, Queen’s Medical Research Institute, Edinburgh, UK

Search for other papers by Frances Collins in
Google Scholar
PubMed

Nozomi Itani

Nozomi Itani The University of Edinburgh Centre for Inflammation Research, Queen’s Medical Research Institute, Edinburgh, UK

Search for other papers by Nozomi Itani in
Google Scholar
PubMed

Arantza Esnal-Zufiaurre

Arantza Esnal-Zufiaurre The University of Edinburgh Centre for Inflammation Research, Queen’s Medical Research Institute, Edinburgh, UK

Search for other papers by Arantza Esnal-Zufiaurre in
Google Scholar
PubMed

Douglas A Gibson

Douglas A Gibson The University of Edinburgh Centre for Inflammation Research, Queen’s Medical Research Institute, Edinburgh, UK

Search for other papers by Douglas A Gibson in
Google Scholar
PubMed

Carol Fitzgerald

Carol Fitzgerald The University of Edinburgh Centre for Inflammation Research, Queen’s Medical Research Institute, Edinburgh, UK

Search for other papers by Carol Fitzgerald in
Google Scholar
PubMed

, and

Philippa T K Saunders

Philippa T K Saunders The University of Edinburgh Centre for Inflammation Research, Queen’s Medical Research Institute, Edinburgh, UK

Search for other papers by Philippa T K Saunders in
Google Scholar
PubMed

changing demographics characterized by an aging population and increased prevalence of obesity ( Sanderson et al. 2017 ). Clinically, endometrial cancers are routinely classified as having a type I or type II phenotype, with the former being oestrogen

Article Type:: Research Article

DOI:: https://doi.org/10.1530/ERC-19-0291

Volume/Issue:: Volume 27: Issue 2

Open access

Is oestrogen receptor- β a predictor of endocrine therapy responsiveness in human breast cancer?

Leigh C Murphy

Leigh C Murphy
Search for other papers by Leigh C Murphy in
Google Scholar
PubMed

and

Peter H Watson

Peter H Watson
Search for other papers by Peter H Watson in
Google Scholar
PubMed

Introduction Oestrogens are pivotal in the growth and development of both normal and neoplastic mammary tissues ( Kelsey 1993 ), and mediate most of their action via ligand-dependent transcription factors called oestrogen receptors

Article Type:: Review Article

DOI:: https://doi.org/10.1677/erc.1.01141

Volume/Issue:: Volume 13: Issue 2

Free access

A phosphorylation code for oestrogen receptor-α predicts clinical outcome to endocrine therapy in breast cancer

Georgios P Skliris

Georgios P Skliris Department of Biochemistry and Medical Genetics, Manitoba Institute of Cell Biology, Department of Structural and Cellular Biology, Manitoba Breast Tumour Bank, Tumour Tissue Repository and Deeley Research Centre, Faculty of Medicine
Department of Biochemistry and Medical Genetics, Manitoba Institute of Cell Biology, Department of Structural and Cellular Biology, Manitoba Breast Tumour Bank, Tumour Tissue Repository and Deeley Research Centre, Faculty of Medicine

Search for other papers by Georgios P Skliris in
Google Scholar
PubMed

Zoann J Nugent

Zoann J Nugent Department of Biochemistry and Medical Genetics, Manitoba Institute of Cell Biology, Department of Structural and Cellular Biology, Manitoba Breast Tumour Bank, Tumour Tissue Repository and Deeley Research Centre, Faculty of Medicine

Search for other papers by Zoann J Nugent in
Google Scholar
PubMed

Brian G Rowan

Brian G Rowan Department of Biochemistry and Medical Genetics, Manitoba Institute of Cell Biology, Department of Structural and Cellular Biology, Manitoba Breast Tumour Bank, Tumour Tissue Repository and Deeley Research Centre, Faculty of Medicine

Search for other papers by Brian G Rowan in
Google Scholar
PubMed

Carla R Penner

Carla R Penner Department of Biochemistry and Medical Genetics, Manitoba Institute of Cell Biology, Department of Structural and Cellular Biology, Manitoba Breast Tumour Bank, Tumour Tissue Repository and Deeley Research Centre, Faculty of Medicine

Search for other papers by Carla R Penner in
Google Scholar
PubMed

Peter H Watson

Peter H Watson Department of Biochemistry and Medical Genetics, Manitoba Institute of Cell Biology, Department of Structural and Cellular Biology, Manitoba Breast Tumour Bank, Tumour Tissue Repository and Deeley Research Centre, Faculty of Medicine
Department of Biochemistry and Medical Genetics, Manitoba Institute of Cell Biology, Department of Structural and Cellular Biology, Manitoba Breast Tumour Bank, Tumour Tissue Repository and Deeley Research Centre, Faculty of Medicine
Department of Biochemistry and Medical Genetics, Manitoba Institute of Cell Biology, Department of Structural and Cellular Biology, Manitoba Breast Tumour Bank, Tumour Tissue Repository and Deeley Research Centre, Faculty of Medicine

Search for other papers by Peter H Watson in
Google Scholar
PubMed

, and

Leigh C Murphy

Leigh C Murphy Department of Biochemistry and Medical Genetics, Manitoba Institute of Cell Biology, Department of Structural and Cellular Biology, Manitoba Breast Tumour Bank, Tumour Tissue Repository and Deeley Research Centre, Faculty of Medicine
Department of Biochemistry and Medical Genetics, Manitoba Institute of Cell Biology, Department of Structural and Cellular Biology, Manitoba Breast Tumour Bank, Tumour Tissue Repository and Deeley Research Centre, Faculty of Medicine

Search for other papers by Leigh C Murphy in
Google Scholar
PubMed

Introduction Oestrogen receptor (ERα) status of breast tumours is an imperfect marker of endocrine therapy response ( Osborne 1998 a , b ), and there is a need for more precise biomarkers of treatment response. ERα is regulated by post